Urolog. pro Praxi, 2003; 2: 55-57

Nežádoucí účinky léčiv na funkci dolních cest močových

MUDr. Jan Krhut, MUDr. Karel Mainer Ph.D
Urologické oddělení FNsP Ostrava

Keywords: side effects, urine retention, incontinence, dysuria.

Published: December 31, 2003  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Krhut J, Mainer K. Nežádoucí účinky léčiv na funkci dolních cest močových. Urol. praxi. 2003;4(2):55-57.

Poruchy funkce dolních cest močových patří k nejčastějším potížím, se kterými se nemocní obracejí na urologa. V současné době disponujeme relativně velmi dokonalými technickými prostředky k diagnostice dysfunkcí močových cest. V úvahách o etiologii těchto poruch však bývá často opomíjena možnost nežádoucích účinků léčiv, užívaných pacientem z jiné indikace. Práce přináší základní přehled farmak, jež mohou mít vliv na funkční stav dolních močových cest s důrazem na využitelnost v denní klinické praxi.

Drug-s side effects to lower urinary tract function

Lower urinary tract dysfunction belongs among the most frequent complaints leading the patients to urologist. Nowadays, we are equipped with relatively sophisticated technical devices for lower urinary tract dysfunction diagnostic. In debates concerning an etiology of these disorders is usually forgotten a possible participation of side effects from drugs administered to patients due to the different diagnosis. This article presents basis summary of drugs, which can affect lower urinary tract function with an emphasis to common practice.

Download citation

References

  1. Buchbinder R, Forbes A, Kobben F, Boyd I, Snow RM, McNeil JJ. Clinical features of tiaprofenic acid (Surgam) associated cystitis and a study of risk factors for its development. J Clin Epidemiol 2000; 53(10): 1013. Go to original source... Go to PubMed...
  2. Casanova JE. Incontinence after use of enalapril. J Urol 1990; 143(6): 1237. Go to original source... Go to PubMed...
  3. Dwyer PL, Desmedt E. Impaired bladder emptying in women. Aust N Z J Obstet Gynaecol 1994; 34: 73. Go to original source... Go to PubMed...
  4. Flamant G, Gillet JY. Drug therapy of female urinary incontinence. Presse Med 1995; 24 (1): 31. Go to PubMed...
  5. Garnier R, Azoyan P, Chataigner D, Taboulet P, Dellattre D, Efthymiou ML. Acute fluvoxamine poisoning. J Int Med Res 1993; 21(4): 197. Go to original source... Go to PubMed...
  6. Ghose K. Cystitis and nonsteroidal antiinflammatory drugs: an incidental association or an adverse effect? N Z Med J 1993; 106 (968): 501. Go to PubMed...
  7. Gormley EA, Griffiths DJ, McCracken PN, Harrison GM. Polypharmacy and its effect on urinary incontinence in a geriatric population. Br J Urol 1993; 71(3): 265. Go to original source... Go to PubMed...
  8. Harrison WJ, Willis RG, Neal DE. Adverse reactions to tiaprofenic acid mimicking interstitial cystitis. BMJ 1994; 309: 574. Go to original source... Go to PubMed...
  9. Hume AL, Murphy JL, Lauerman SE. Angiotensin-converting enzyme inhibitor-induced cough. Pharmacotherapy 1989; 9(2): 88. Go to original source... Go to PubMed...
  10. Jacobsen SJ, Jacobson DJ, Girman CJ, Roberts RO, Rhodes T, Guess HA, Lieber MM. Natural history of prostatism: risk factors for acute urinary retention. J Urol 1997; 158(2): 481. Go to original source... Go to PubMed...
  11. Katsumi T, Murayama K, Tajika E, Nakamura T, Kawaguchi K. Clinical studies of terodiline hydrochloride and clenbuterol hydrochloride for urinary frequency and incontinence. Hinyokika Kiyo 1991; 37(11): 1575. Go to PubMed...
  12. Madersbacher H, Awad S, Fall M, Jangknegt RA, Stöhrer M, Weisner B. WHO-Statements: Urge Inkontinenz beim älteren Menschen - supraspinale Reflexinkontinenz. Urologe B 1998; 38(Suppl 2): 10. Go to original source...
  13. Malinovsky JM, Le Normand L, Lepage JY, Malinge M, Cozian A, Pinaud M, Buzelin JM. The urodynamic effects of intravenous opioids and ketoprofen in humans. Anesth Analg 1998; 87(2): 456. Go to original source... Go to PubMed...
  14. Menefee SA, Chesson R, Wall LL. Stress urinary incontinence due to prescription medications: alpha-blockers and angiotensin converting enzyme inhibitors. Obstet Gynecol 1998; 91: 853. Go to original source...
  15. O'Neill GF: Tiaprofenic acid as a cause of non-bacterial cystitis. Med J Aust 1994; 160: 125. Go to original source...
  16. Pannill FD, Williams TF, Davis R: Evaluation and treatment of urinary incontinence in long term care. J Am Geriatr Soc 1988; 36: 902. Go to original source... Go to PubMed...
  17. Pras E, Stienlauf SH, Pinkhas J, Sidi Y: Urinary retention associated with ipratropium bromide. DICP Ann P 1991; 25: 939. Go to original source... Go to PubMed...
  18. Rachagan SP, Mathews A: Urinary incontinence caused by prazosin. Singapore Med J 1992; 33(3): 308. Go to PubMed...
  19. Richelson E: Antimuscarinic and other receptor-blocking properties of antidepressants. Mayo Clin Proc 1983; 58(1): 40.
  20. Robinson JM, Brocklehurst JC: Emepromium bromide and flavoxate hydrochloride in the treatment of the urinary incontinence associated with detrusor instability in elderly women. Br J Urol 1983; 55: 371. Go to original source... Go to PubMed...
  21. Seggev JS, Fink JN: Urinary retention as a result of administration of terfenadine. J Allergy Clin Immunol 1994; 93: 1071. Go to original source... Go to PubMed...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.